financetom
Business
financetom
/
Business
/
Trinity Biotech Raises 2024 Sales Revenue Outlook After Additional Orders -- Shares Surge
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Trinity Biotech Raises 2024 Sales Revenue Outlook After Additional Orders -- Shares Surge
Aug 29, 2024 2:16 AM

04:33 PM EDT, 08/26/2024 (MT Newswires) -- Trinity Biotech ( TRIB ) said Monday it received substantial additional orders for TrinScreen HIV and is increasing its 2024 sales revenue outlook for the product to $10 million from $8 million.

Shares of the company surged over 39% in recent after-hours activity.

Price: 2.8300, Change: +0.80, Percent Change: +39.41

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Airbnb says Spanish government investigating alleged infractions
Airbnb says Spanish government investigating alleged infractions
Dec 18, 2024
MADRID, Dec 18 (Reuters) - Airbnb ( ABNB ) said on Wednesday it was the subject of a Spanish government investigation into potential infractions including listings without permit numbers, adding it would appeal if necessary. (Reporting by Corina Pons; Writing by David Latona; Editing by Inti Landauro) ...
BioAge Labs Says it is Partnering With Novartis to Identify Drug Targets to Treat Age-Related Diseases
BioAge Labs Says it is Partnering With Novartis to Identify Drug Targets to Treat Age-Related Diseases
Dec 18, 2024
09:50 AM EST, 12/18/2024 (MT Newswires) -- BioAge Labs ( BIOA ) said Wednesday it is teaming up with Novartis ( NVS ) to identify drug targets to treat diseases related to aging. The multiyear research collaboration will use BioAge's ( BIOA ) human longevity data and platform and Novartis' ( NVS ) expertise in physical exercise biology, BioAge (...
RTX's Raytheon, Ursa Major Complete Long-Range Missile Test for US Army
RTX's Raytheon, Ursa Major Complete Long-Range Missile Test for US Army
Dec 18, 2024
09:57 AM EST, 12/18/2024 (MT Newswires) -- RTX's (RTX) Raytheon unit and privately held aerospace company Ursa Major said Wednesday they have successfully completed a missile flight test of a long-range solid rocket motor for the US Army. The companies said the next phase of the program will involve incorporating manufacturing improvements prior to additional flight tests in 2025 and...
Astrazeneca's Alexion Pharma Signs LOI With Pan-Canadian Pharmaceutical Alliance for Koselugo
Astrazeneca's Alexion Pharma Signs LOI With Pan-Canadian Pharmaceutical Alliance for Koselugo
Dec 18, 2024
09:55 AM EST, 12/18/2024 (MT Newswires) -- Astrazeneca's ( AZN ) rare disease group Alexion Pharma Canada said Wednesday it signed a letter of intent with the pan-Canadian Pharmaceutical Alliance for Koselugo to treat pediatric patients aged at least two years with neurofibromatosis type 1 who have symptomatic, inoperable plexiform neurofibromas. With the agreement in place, individual provinces and territories...
Copyright 2023-2026 - www.financetom.com All Rights Reserved